The newly released Global Swine Vaccine Market analysis report by Future Market Insights reveals that the global market for Swine Vaccine was held at around USD 1.5 Billion in 2021, and is projected to grow at a CAGR of 5.8% from 2022 to 2032. The market is expected to surge with an absolute dollar opportunity of USD 1.2 Billion. The projected market growth is expected to cross the historical CAGR of 4.9%.
The Inactivated Vaccines segment is likely to outpace all the other segments by growing at a CAGR of 5.9% from 2022 to 2032. Furthermore, Porcine Circovirus Type 2 was the top type segment in the global market. Revenue through this segment is expected to grow at a CAGR of 5.6% during the forecasted period.
| Attribute | Details |
|---|---|
| Global Swine Vaccines Market (2022) | USD 1.6 Billion |
| Global Swine Vaccines Market (2032) | USD 2.8 Billion |
| Global Swine Vaccines Market CAGR (2022 to 2032) | 5.8% |
| USA Swine Vaccines Market CAGR (2022 to 2032) | 6% |
| Key Companies Profiled | Merck Animal Health; Ceva; Zoetis; Boehringer Ingelheim GmbH; Elanco; Indian Immunologicals Ltd.; BiogénesisBagó; Phibro Animal Health; KM Biologics; HIPRA |
The global market for Swine Vaccines is likely to be driven by increased demand for animal protein and surged Research and Development expenditure for vaccine innovation. Swine production is vital to global food security, agricultural countries, and domestic and international trade.
Contagious diseases have a global impact on pig health, as well as the swine industry's stability and production. As a result, increased swine disease prevalence is expected to boost the market in the coming years. Furthermore, leading players' increasing efforts in developing improved products for better diagnostics are expected to drive market expansion.
As per the Swine Vaccine Market research by Future Market Insights - a market research and competitive intelligence provider, historically, from 2017 to 2021, the market value of the Swine Vaccine increased at a CAGR of around 4.9%, while the USA held the majority share of over 35% in the global market.
The market is being driven by increased disease prevalence, increased demand for animal protein, and increased Research and Development expenditure for vaccine innovation. Owing to this, the market for Swine Vaccines is projected to grow at a CAGR of 5.8% during the forecasted period.
Some of the key factors driving the growth of the Swine Vaccine market are the rising prevalence of swine diseases like PPV, Porcine Reproductive and Respiratory Syndrome (PRRS), and Classical Swine Fever, which are likely to cause economic losses due to their negative effects on reproduction and growth in pig farms.
Swine meat is vital for agriculture-based countries and it considerably affects domestic and international trade. Contagious diseases have a global impact on pig health, as well as the swine industry's stability and production. As a result, the increased prevalence of swine disease is expected to boost the market in the coming years.
Putting in place a pig vaccination program helps in protecting them from infectious diseases at every stage of their development. As a result, businesses are concentrating on providing immunization services to assist farmers to manage bacteria and viruses more effectively.
The rise in demand for animal protein, along with rising consumer preferences for a low-fat, high-protein diet like pork has resulted in a significant increase in animal protein consumption around the world.
APAC dominated the Swine Vaccine Market, where China led the regional demand. The consumption of beef and pork is higher in middle-income countries, particularly in Southeast Asia.
In addition, emerging infectious diseases in the region, such as swine fever, drive product demand even further. In India, CSF results in an annual loss of approximately 400 crores. As a result, the Indian government is placing a greater emphasis on the development of new vaccines. In October 2019, for example, the ICAR-Indian Veterinary Research Institute developed two diagnostic kits for Swine Control and Antigen Detection. These factors are leading to the expansion of the swine vaccine market in APAC.
The market for swine vaccines in the USA is expected to reach a valuation of USD 319 Million by 2032. With a CAGR of 6% during the forecast period, the market in the country is projected to gross an absolute dollar opportunity of USD 137 Million.
The market in the UK is projected to reach a valuation of USD 112 Million by 2032. Growing at a CAGR of 6.1% during the forecast period, the market is expected to garner an absolute dollar opportunity of around USD 48 Million.
In China, the market is projected to expand at a CAGR of 6.9% during 2022 to 2032. The market in the country is projected to reach USD 1.1 Billion by 2032, grossing an absolute dollar opportunity of USD 463 Million during the forecast period.
In Japan, the market is expected to reach a valuation of USD 224 Million by 2032. With a CAGR of 7.5%, the market in the country is expected to gross an absolute dollar opportunity of USD 96 Million by 2032.
The market for Inactivated Vaccines is gaining the utmost traction and is expected to grow at a CAGR of 5.9% between 2022 and 2032. This increase in growth is attributable to easy availability, low cost, low risk of revert reaction of destroyed viruses, and fresh advances by key companies. For Example, PARVOVAX and PROGRESSIS vaccines were developed to fight against Porcine parvovirus and PRRS.
From 2022 to 2032, the recombinant vaccine category is projected to grow at the fastest rate. Because recombinants can carry many gene inserts, these vaccines are expected to aid in the vaccination of multiple viral strains.
Porcine Circovirus Type 2 is expected to dominate the global market and is expected to grow with a CAGR of 5.6% during the forecast period. PCV2 is the single-stranded DNA having the highest mutation and recombination rate among all single-stranded DNA viruses. It can be spread through an infected pig and is one of the most prevalent infectious agents affecting pig productivity. As a result, during the forecast period, it will contribute to a significant market share.
Some of the key competitors in the Swine Vaccine Market are Merck Animal Health, Ceva, Zoetis, Boehringer Ingelheim GmbH, Elanco, Indian Immunologicals Ltd., BiogénesisBagó, Phibro Animal Health, KM Biologics, and HIPRA.
Some of the recent developments in the Swine Vaccine Market are as follows:
Similarly, recent developments related to companies offering Swine Vaccine have been tracked by the team at Future Market Insights, which are available in the full report.
Table 1: Global Market Value (US$ Million), By Type, 2017 to 2021
Table 2: Global Market Value (US$ Million), By Type, 2022 to 2032
Table 3: Global Market Value (US$ Million), By Product, 2017 to 2021
Table 4: Global Market Value (US$ Million), By Product, 2022 to 2032
Table 5: Global Market, By Region, 2017 to 2021
Table 6: Global Market, By Region, 2022 to 2032
Table 7: North America Market Value (US$ Million), By Type, 2017 to 2021
Table 8: North America Market Value (US$ Million), By Type, 2022 to 2032
Table 9: North America Market Value (US$ Million), By Product, 2017 to 2021
Table 10: North America Market Value (US$ Million), By Product, 2022 to 2032
Table 11: North America Market, By Country, 2017 to 2021
Table 12: North America Market, By Country, 2022 to 2032
Table 13: Latin America Market Value (US$ Million), By Type, 2017 to 2021
Table 14: Latin America Market Value (US$ Million), By Type, 2022 to 2032
Table 15: Latin America Market Value (US$ Million), By Product, 2017 to 2021
Table 16: Latin America Market Value (US$ Million), By Product, 2022 to 2032
Table 17: Latin America Market, By Country, 2017 to 2021
Table 18: Latin America Market, By Country, 2022 to 2032
Table 19: Europe Market Value (US$ Million), By Type, 2017 to 2021
Table 20: Europe Market Value (US$ Million), By Type, 2022 to 2032
Table 21: Europe Market Value (US$ Million), By Product, 2017 to 2021
Table 22: Europe Market Value (US$ Million), By Product, 2022 to 2032
Table 23: Europe Market, By Country, 2017 to 2021
Table 24: Europe Market, By Country, 2022 to 2032
Table 25: Asia Pacific Market Value (US$ Million), By Type, 2017 to 2021
Table 26: Asia Pacific Market Value (US$ Million), By Type, 2022 to 2032
Table 27: Asia Pacific Market Value (US$ Million), By Product, 2017 to 2021
Table 28: Asia Pacific Market Value (US$ Million), By Product, 2022 to 2032
Table 29: Asia Pacific Market, By Country, 2017 to 2021
Table 30: Asia Pacific Market, By Country, 2022 to 2032
Table 31: MEA Market Value (US$ Million), By Type, 2017 to 2021
Table 32: MEA Market Value (US$ Million), By Type, 2022 to 2032
Table 33: MEA Market Value (US$ Million), By Product, 2017 to 2021
Table 34: MEA Market Value (US$ Million), By Product, 2022 to 2032
Table 35: MEA Market, By Country, 2017 to 2021
Table 36: MEA Market, By Country, 2022 to 2032
Table 37: Global Market Incremental $ Opportunity, By Type, 2017 to 2021
Table 38: Global Market Incremental $ Opportunity, By Product, 2022 to 2032
Table 39: Global Market Incremental $ Opportunity, By Region, 2022 to 2032
Table 40: North America Market Incremental $ Opportunity, By Type, 2017 to 2021
Table 41: North America Market Incremental $ Opportunity, By Product, 2022 to 2032
Table 42: North America Market Incremental $ Opportunity, By Country, 2022 to 2032
Table 43: Latin America Market Incremental $ Opportunity, By Type, 2017 to 2021
Table 44: Latin America Market Incremental $ Opportunity, By Product, 2022 to 2032
Table 45: Latin America Market Incremental $ Opportunity, By Country, 2022 to 2032
Table 46: Europe Market Incremental $ Opportunity, By Type, 2017 to 2021
Table 47: Europe Market Incremental $ Opportunity, By Product, 2022 to 2032
Table 48: Europe Market Incremental $ Opportunity, By Country, 2022 to 2032
Table 49: Asia Pacific Market Incremental $ Opportunity, By Type, 2017 to 2021
Table 50: Asia Pacific Market Incremental $ Opportunity, By Product, 2022 to 2032
Table 51: Asia Pacific Market Incremental $ Opportunity, By Country, 2022 to 2032
Table 52: MEA Market Incremental $ Opportunity, By Type, 2017 to 2021
Table 53: MEA Market Incremental $ Opportunity, By Product, 2022 to 2032
Table 54: MEA Market Incremental $ Opportunity, By Country, 2022 to 2032
Figure 1: Global Market Value (US$ Million) and Year-on-Year Growth, 2017 to 2032
Figure 2: Global Market Absolute $ Historical Gain (2017 to 2021) and Opportunity (2022 to 2032), US$ Million
Figure 3: Global Market Share, By Type, 2022 to 2032
Figure 4: Global Market Y-o-Y Growth Projections, By Type - 2022 to 2032
Figure 5: Global Market Attractiveness Index, By Type - 2022 to 2032
Figure 6: Global Market Share, By Product, 2022 to 2032
Figure 7: Global Market Y-o-Y Growth Projections, By Product - 2022 to 2032
Figure 8: Global Market Attractiveness Index, By Product - 2022 to 2032
Figure 9: Global Market Share, By Region, 2022 to 2032
Figure 10: Global Market Y-o-Y Growth Projections, By Region - 2022 to 2032
Figure 11: Global Market Attractiveness Index, By Region - 2022 to 2032
Figure 12: North America Market Value (US$ Million) and Year-on-Year Growth, 2017 to 2032
Figure 13: North America Market Absolute $ Opportunity Historical (2017 to 2021) and Forecast Period (2022 to 2032), US$ Million
Figure 14: North America Market Share, By Type, 2022 to 2032
Figure 15: North America Market Y-o-Y Growth Projections, By Type - 2022 to 2032
Figure 16: North America Market Attractiveness Index, By Type - 2022 to 2032
Figure 17: North America Market Share, By Product, 2022 to 2032
Figure 18: North America Market Y-o-Y Growth Projections, By Product - 2022 to 2032
Figure 19: North America Market Attractiveness Index, By Product - 2022 to 2032
Figure 20: North America Market Share, By Country, 2022 to 2032
Figure 21: North America Market Y-o-Y Growth Projections, By Country - 2022 to 2032
Figure 22: North America Market Attractiveness Index, By Country - 2022 to 2032
Figure 23: Latin America Market Value (US$ Million) and Year-on-Year Growth, 2017 to 2032
Figure 24: Latin America Market Absolute $ Opportunity Historical (2017 to 2021) and Forecast Period (2022 to 2032), US$ Million
Figure 25: Latin America Market Share, By Type, 2022 to 2032
Figure 26: Latin America Market Y-o-Y Growth Projections, By Type - 2022 to 2032
Figure 27: Latin America Market Attractiveness Index, By Type - 2022 to 2032
Figure 28: Latin America Market Share, By Product, 2022 to 2032
Figure 29: Latin America Market Y-o-Y Growth Projections, By Product - 2022 to 2032
Figure 30: Latin America Market Attractiveness Index, By Product - 2022 to 2032
Figure 31: Latin America Market Share, By Country, 2022 to 2032
Figure 32: Latin America Market Y-o-Y Growth Projections, By Country - 2022 to 2032
Figure 33: Latin America Market Attractiveness Index, By Country - 2022 to 2032
Figure 34: Europe Market Value (US$ Million) and Year-on-Year Growth, 2017 to 2032
Figure 35: Europe Market Absolute $ Opportunity Historical (2017 to 2021) and Forecast Period (2022 to 2032), US$ Million
Figure 36: Europe Market Share, By Type, 2022 to 2032
Figure 37: Europe Market Y-o-Y Growth Projections, By Type - 2022 to 2032
Figure 38: Europe Market Attractiveness Index, By Type - 2022 to 2032
Figure 39: Europe Market Share, By Product, 2022 to 2032
Figure 40: Europe Market Y-o-Y Growth Projections, By Product - 2022 to 2032
Figure 41: Europe Market Attractiveness Index, By Product - 2022 to 2032
Figure 42: Europe Market Share, By Country, 2022 to 2032
Figure 43: Europe Market Y-o-Y Growth Projections, By Country - 2022 to 2032
Figure 44: Europe Market Attractiveness Index, By Country - 2022 to 2032
Figure 45: MEA Market Value (US$ Million) and Year-on-Year Growth, 2017 to 2032
Figure 46: MEA Market Absolute $ Opportunity Historical (2017 to 2021) and Forecast Period (2022 to 2032), US$ Million
Figure 47: MEA Market Share, By Type, 2022 to 2032
Figure 48: MEA Market Y-o-Y Growth Projections, By Type - 2022 to 2032
Figure 49: MEA Market Attractiveness Index, By Type - 2022 to 2032
Figure 50: MEA Market Share, By Product, 2022 to 2032
Figure 51: MEA Market Y-o-Y Growth Projections, By Product - 2022 to 2032
Figure 52: MEA Market Attractiveness Index, By Product - 2022 to 2032
Figure 53: MEA Market Share, By Country, 2022 to 2032
Figure 54: MEA Market Y-o-Y Growth Projections, By Country - 2022 to 2032
Figure 55: MEA Market Attractiveness Index, By Country - 2022 to 2032
Figure 56: Asia Pacific Market Value (US$ Million) and Year-on-Year Growth, 2017 to 2032
Figure 57: Asia Pacific Market Absolute $ Opportunity Historical (2017 to 2021) and Forecast Period (2022 to 2032), US$ Million
Figure 58: Asia Pacific Market Share, By Type, 2022 to 2032
Figure 59: Asia Pacific Market Y-o-Y Growth Projections, By Type - 2022 to 2032
Figure 60: Asia Pacific Market Attractiveness Index, By Type - 2022 to 2032
Figure 61: Asia Pacific Market Share, By Product, 2022 to 2032
Figure 62: Asia Pacific Market Y-o-Y Growth Projections, By Product - 2022 to 2032
Figure 63: Asia Pacific Market Attractiveness Index, By Product - 2022 to 2032
Figure 64: Asia Pacific Market Share, By Country, 2022 to 2032
Figure 65: Asia Pacific Market Y-o-Y Growth Projections, By Country - 2022 to 2032
Figure 66: Asia Pacific Market Attractiveness Index, By Country - 2022 to 2032
Figure 67: US Market Value (US$ Million) and Forecast, 2022 to 2032
Figure 68: US Market Share, By Type, 2021
Figure 69: US Market Share, By Product, 2021
Figure 70: Canada Market Value (US$ Million) and Forecast, 2022 to 2032
Figure 71: Canada Market Share, By Type, 2021
Figure 72: Canada Market Share, By Product, 2021
Figure 73: Brazil Market Value (US$ Million) and Forecast, 2022 to 2032
Figure 74: Brazil Market Share, By Type, 2021
Figure 75: Brazil Market Share, By Product, 2021
Figure 76: Mexico Market Value (US$ Million) and Forecast, 2022 to 2032
Figure 77: Mexico Market Share, By Type, 2021
Figure 78: Mexico Market Share, By Product, 2021
Figure 79: Germany Market Value (US$ Million) and Forecast, 2022 to 2032
Figure 80: Germany Market Share, By Type, 2021
Figure 81: Germany Market Share, By Product, 2021
Figure 82: UK Market Value (US$ Million) and Forecast, 2022 to 2032
Figure 83: UK Market Share, By Type, 2021
Figure 84: UK Market Share, By Product, 2021
Figure 85: France Market Value (US$ Million) and Forecast, 2022 to 2032
Figure 86: France Market Share, By Type, 2021
Figure 87: France Market Share, By Product, 2021
Figure 88: Italy Market Value (US$ Million) and Forecast, 2022 to 2032
Figure 89: Italy Market Share, By Type, 2021
Figure 90: Italy Market Share, By Product, 2021
Figure 91: BENELUX Market Value (US$ Million) and Forecast, 2022 to 2032
Figure 92: BENELUX Market Share, By Type, 2021
Figure 93: BENELUX Market Share, By Product, 2021
Figure 94: Nordic Countries Market Value (US$ Million) and Forecast, 2022 to 2032
Figure 95: Nordic Countries Market Share, By Type, 2021
Figure 96: Nordic Countries Market Share, By Product, 2021
Figure 97: China Market Value (US$ Million) and Forecast, 2022 to 2032
Figure 98: China Market Share, By Type, 2021
Figure 99: China Market Share, By Product, 2021
Figure 100: Japan Market Value (US$ Million) and Forecast, 2022 to 2032
Figure 101: Japan Market Share, By Type, 2021
Figure 102: Japan Market Share, By Product, 2021
Figure 103: South Korea Market Value (US$ Million) and Forecast, 2022 to 2032
Figure 104: South Korea Market Share, By Type, 2021
Figure 105: South Korea Market Share, By Product, 2021
Figure 106: GCC Countries Market Value (US$ Million) and Forecast, 2022 to 2032
Figure 107: GCC Countries Market Share, By Type, 2021
Figure 108: GCC Countries Market Share, By Product, 2021
Figure 109: South Africa Market Value (US$ Million) and Forecast, 2022 to 2032
Figure 110: South Africa Market Share, By Type, 2021
Figure 111: South Africa Market Share, By Product, 2021
Figure 112: Turkey Market Value (US$ Million) and Forecast, 2022 to 2032
Figure 113: Turkey Market Share, By Type, 2021
Figure 114: Turkey Market Share, By Product, 2021
The Global Swine Vaccine Market is currently valued at USD 1.5 billion and is expected to reach a valuation of USD 1.6 billion by the end of 2022.
The Global Market for Swine Vaccine is expected to provide an Absolute Dollar Opportunity of USD 1.2 billion during the period between 2022 and 2032 by growing at a CAGR of 5.8%.
The Inactivated Vaccines segment is likely to maintain its dominance and is expected to grow at a CAGR of 5.9% during the forecast period. This growth is attributable to easy availability, low cost, low risk of revert reaction of destroyed viruses, and fresh advances by key companies.
The key players operating in the Swine Vaccine market are Merck Animal Health, Ceva, Zoetis, Boehringer Ingelheim GmbH, Elanco, Indian Immunologicals Ltd., BiogénesisBagó, Phibro Animal Health, KM Biologics, and HIPRA.
Explore Similar Insights
Swine Vaccine Market
Thank you!
You will receive an email from our Business Development Manager. Please be sure to check your SPAM/JUNK folder too.
